In April 2024, Astellas filed a supplemental New Drug Application with the FDA, seeking to add two-year data to Izervays label
Given the FDAs April 2025 alert, informed consent for compounded topical finasteride should cover systemic absorption risk, known side effects (sexual, neuropsychiatric), transfer risk to household members (especially women of childbearing age), and the non-FDA-approved status of the formulation
At this time, there are no known adverse reactions when taken in conjunction with medications
In skincare research, its widely discussed for supporting the look of firmness, elasticity, texture, and a healthier-looking complexion
426432, Jul
90-Day On / 30-Day Off This is perhaps the most widely reported cycling pattern: Use Dihexa daily for approximately 90 days (13 weeks) Discontinue completely for 30 days (4 weeks) Repeat the cycle Rationale: Allows receptor sensitivity to reset and minimizes tolerance No scientific evidence supports this particular cycle length 5-Days-On / 2-Days-Off A shorter cycle pattern used by some: Take Dihexa for 5 consecutive days, then skip 2 days Repeat weekly Provides more frequent breaks without long discontinuation Anecdotally reported to maintain responsiveness Continuous Use Some community members report continuous daily use without cycling: Effects may be maintained or may plateau Risk of tolerance development is unknown Long-term safety of continuous use is not established Important Note on Cycling The concept of receptor tolerance and its mitigation through cycling is theoretically grounded in neuropharmacology